Back to Search Start Over

An integrative pan-cancer analysis of the molecular characteristics of dietary restriction in tumour microenvironmentResearch in context

Authors :
Xiaoyi Song
Jiaxing Wei
Yang Li
Wen Zhu
Zhiyuan Cai
Kunwei Li
Jingyue Wei
Jieyu Lu
Wanping Pan
Man Li
Source :
EBioMedicine, Vol 102, Iss , Pp 105078- (2024)
Publication Year :
2024
Publisher :
Elsevier, 2024.

Abstract

Summary: Background: Dietary restriction (DR), a general term for dieting, has been demonstrated as an effective intervention in reducing the occurrence of cancers. Molecular activities associated with DR are crucial in mediating its anti-cancer effects, yet a comprehensive exploration of the landscape of these activities at the pan-cancer level is still lacking. Methods: We proposed a computational approach for quantifying DR-related molecular activities and delineating the landscape of these activities across 33 cancer types and 30 normal tissues within 27,320 samples. We thoroughly examined the associations between DR-related molecular activities and various factors, including the tumour microenvironment, immunological phenotypes, genomic features, and clinical prognosis. Meanwhile, we identified two DR genes that show potential as prognostic predictors in hepatocellular carcinoma and verified them by immunohistochemical assays in 90 patients. Findings: We found that DR-related molecular activities showed a close association with tumour immunity and hold potential for predicting immunotherapy responses in various cancers. Importantly, a higher level of DR-related molecular activities is associated with improved overall survival and cancer-specific survival. FZD1 and G6PD are two DR genes that serve as biomarkers for predicting the prognosis of patients with hepatocellular carcinoma. Interpretation: This study presents a robust link between DR-related molecular activities and tumour immunity across multiple cancer types. Our research could open the path for further investigation of DR-related molecular processes in cancer treatment. Funding: National Natural Science Foundation of China (Grant No. 82000628) and the Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province (Grant No. 2023LSYS001).

Details

Language :
English
ISSN :
23523964
Volume :
102
Issue :
105078-
Database :
Directory of Open Access Journals
Journal :
EBioMedicine
Publication Type :
Academic Journal
Accession number :
edsdoj.936a35c750f34e8ba22ff4a5a34c645f
Document Type :
article
Full Text :
https://doi.org/10.1016/j.ebiom.2024.105078